Diagnostic performance of nanoparticle-enhanced magnetic resonance Imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer

被引:235
作者
Rockall, AG
Sohaib, SA
Harisinghani, MG
Babar, SA
Singh, N
Jeyarajah, AR
Oram, DH
Jacobs, IJ
Shepherd, JH
Reznek, RH
机构
[1] St Bartholomews Hosp, Dept Radiol, London EC1A 7ED, England
[2] St Bartholomews Hosp, Dept Gyneoncol & Histopathol, London EC1A 7ED, England
[3] Royal Marsden Hosp, Dept Radiol, London SW3 6JJ, England
[4] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA
关键词
D O I
10.1200/JCO.2005.07.166
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Lymph node metastases affect management and prognosis of patients with gynecologic malignancies. Preoperative nodal assessment with computed tomography or magnetic resonance imaging (MRI) is inaccurate. A new lymph node-specific contrast agent, ferumoxtran-10, composed of ultrasmall particles of iron oxide (USPIO), may enhance the detection of lymph node metastases independent of node size. Our aim was to compare the diagnostic performance of MRI with USPIO against standard size criteria. Methods Forty-four patients with endometrial (n = 15) or cervical (n = 29) cancer were included. MRI was performed before and after administration of USPIO. Two independent observers viewed the MR images before lymph node sampling. Lymph node metastases were predicted using size criteria and USPIO criteria Lymph node sampling was performed in all patients. Results Lymph node sampling provided 768 pelvic or para-aortic nodes for pathology, of which 335 were correlated on MRI; 17 malignant nodes were found in 11 of 44 patients (25 %). On a node-by-node basis, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) by size criteria were 29 %*, 99 %, 56 %, and 96 %, and by USPIO criteria (reader 1/reader 2) were 93 %/82 %* (*P = 008/ 004) 97 %/97 % 61 %/59 % and 100 %/99 %, respectively (where [*] indicates the statistical difference of P = x/x between the two results marked by the asterisk). On a patient-by-patient basis, sensitivity, specificity, PPV, and NPV by size criteria were 27 %*, 94 %, 60 %, and 79 %, and by USPIO criteria (reader 1/reader 2) were 100 %/91 %* (*P = .031/.06), 94 %/87 %, 82 %/71 %, and 100 %/ 96 %, respectively. The kappa statistic was 0.93. Conclusion Lymph node characterization with USPIO increases the sensitivity of MRI in the prediction of lymph node metastases, with no loss of specificity. This may greatly improve preoperative treatment planning.
引用
收藏
页码:2813 / 2821
页数:9
相关论文
共 26 条
[1]   Port site metastasis after laparoscopy for uterine cervical carcinoma [J].
Agostini, A ;
Carcopino, X ;
Franchi, F ;
Cravello, L ;
Lécuru, F ;
Blanc, B .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2003, 17 (10) :1663-1665
[2]   Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: Phase III safety and efficacy study [J].
Anzai, Y ;
Piccoli, CW ;
Outwater, EK ;
Stanford, W ;
Bluemke, DA ;
Nurenberg, P ;
Saini, S ;
Maravilla, KR ;
Feldman, DE ;
Schmiedl, UP ;
Brunberg, JA ;
Francis, IR ;
Harms, SE ;
Som, PM ;
Tempany, CM .
RADIOLOGY, 2003, 228 (03) :777-788
[3]   Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review [J].
Bipat, S ;
Glas, AS ;
van der Velden, J ;
Zwinderman, AH ;
Bossuyt, PMM ;
Stoker, J .
GYNECOLOGIC ONCOLOGY, 2003, 91 (01) :59-66
[4]   Adenocarcinoma of the uterine cervix metastatic to lymph nodes [J].
Cohn, DE ;
Peters, WA ;
Muntz, HG ;
Wu, R ;
Greer, BE ;
Tamimi, HK ;
Drescher, CW ;
Smith, MR ;
Yon, JL ;
Schmidt, R ;
Goff, BA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 178 (06) :1131-1137
[5]   METHODS FOR COMPARING EVENT RATES IN INTERVENTION STUDIES WHEN THE UNIT OF ALLOCATION IS A CLUSTER [J].
DONNER, A ;
KLAR, N .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 140 (03) :279-289
[6]  
Fleiss J. L., 1981, Statistical Methods for Rates and Proportions, V2nd
[7]   Lymph node staging by positron emission tomography in patients with carcinoma of the cervix [J].
Grigsby, PW ;
Siegel, BA ;
Dehdashti, F .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (17) :3745-3749
[8]   Noninvasive detection of clinically occult lymph-node metastases in prostate cancer [J].
Harisinghani, MG ;
Barentsz, J ;
Hahn, PF ;
Deserno, WM ;
Tabatabaei, S ;
van de Kaa, CH ;
de la Rosette, J ;
Weissleder, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (25) :2491-U5
[9]   CLINICAL-PATHOLOGICAL STUDY OF STAGE IIB, III, AND IVA CARCINOMA OF THE CERVIX - EXTENDED DIAGNOSTIC EVALUATION FOR PARAAORTIC NODE METASTASIS-A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
HELLER, PB ;
MALFETANO, JH ;
BUNDY, BN ;
BARNHILL, DR ;
OKAGAKI, T .
GYNECOLOGIC ONCOLOGY, 1990, 38 (03) :425-430
[10]   Laparoscopic staging compared with imaging techniques in the staging of advanced cervical cancer [J].
Hertel, H ;
Köhler, C ;
Elhawary, T ;
Michels, W ;
Possover, M ;
Schneider, A .
GYNECOLOGIC ONCOLOGY, 2002, 87 (01) :46-51